Mitochondriacs · La DAO des Mitos

Curation rules

These are the rules every tier, review, and flag is held to — public, so you always know how a label was earned. They do not change with a vote.

The four principles
1 · Honesty before consensus

No claim is published without a tier. No tier is overridden by a vote. We never present speculation as settled fact.

2 · Powers do not overlap

A role that makes an epistemic decision cannot also control funds, and vice versa. Reviewers tier; stewards fund. Neither does the other's job.

3 · Decentralization where it protects, not where it costs

We mirror infrastructure and distribute ownership so no single party can take the commons down. We do not token-gate scientific content.

4 · Transparency by default

Decisions, funds, and identity are public unless a specific harm requires otherwise.

The four evidence tiers
TierMeaning
T1 · EstablishedReplicated, peer-reviewed consensus — a settled core fact.
T2 · EmergingSeveral independent studies, converging — promising, not yet replicated.
T3 · PreliminaryA single study or plausible mechanism — early and unconfirmed.
T4 · SpeculativeHypothesis, anecdote or theory — no direct evidence yet.
Two wings, always separated

Core

Peer-reviewed biology — bioenergetics, inner-membrane physics, evolution, health and disease. The default view and featured content are at least 70% Core.

Exploratory

Developing and contested ideas — EZ water, quantum biology, PEMF, bioelectronics. Welcome, but contained: every entry states in plain text what it does not establish, and any commercial conflict must be disclosed.

Who can assign — and who can override
Reviewers · domain-credentialed

The only role that assigns tiers

Admitted by co-optation on a publication record — at least one first- or corresponding-author paper in the field, verified against ORCID. Two existing reviewers admit you.

The two-reviewer rule

Provisional → final

One reviewer's tier is provisional; a second agreeing makes it final; a disagreement escalates to a panel of three, whose call stands on the evidence.

No steward may override a tier

Challenge, not overrule

A tier dispute is re-reviewed by a different reviewer — never the original — within thirty days. That outcome is itself versioned and citable. This is the only path by which a tier changes.

Conflict, marketing, overclaiming

Disclose conflicts. A commercial interest in a claim — a supplement, a device, a clinic, anything — must be disclosed before you act on it. Undisclosed conflict means the work is flagged and demoted.

No overclaiming. If the evidence is T4, it is labelled T4 — no dressing speculation as consensus, no "this cures" language. A clinical claim requires at least T2 evidence.

Education, not medical advice. The archive is a knowledge commons. No entry is a diagnosis or a treatment recommendation, and that disclaimer rides on every entry.

Start contributing Open the Radar →